buflomedil hydrochloride

Miscellaneous compounds - Buflomedil Hydrochloride is used to treat the symptoms of peripheral arterial occlusive disease (PAOD), a condition where the body's large arteries become obstructed causing symptoms such as pain and weakness, particularly in the legs.. Reference standards of Buflomedil Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => 4-(1-Pyrrolidino)butyronitrile
    [catalogue_number] => PA 02 56510
    [category_ids] => ,84,
    [chemical_name] => 
    [weight] => 138.21
    [form] => C8H14N2
    [cas] => 35543-25-0
    [pslug] => 35543-25-0-4-1-pyrrolidino-butyronitrile-pa0256510
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 02 56510
PA 02 56510

4-(1-Pyrrolidino)butyronitrile


  • Catalogue No.:PA 02 56510

  • CAS :

    35543-25-0

  • Molecular Formula : C8H14N2

  • Molecular Weight : 138.21

stdClass Object
(
    [pname] => 1,3,5-Trimethoxybenzene
    [catalogue_number] => PA 02 56520
    [category_ids] => ,80,84,
    [chemical_name] => 
    [weight] => 168.19
    [form] => C9H12O3
    [cas] => 621-23-8
    [pslug] => 621-23-8-1-3-5-trimethoxybenzene-pa0256520
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 02 56520
PA 02 56520

1,3,5-Trimethoxybenzene


  • Catalogue No.:PA 02 56520

  • CAS :

    621-23-8

  • Molecular Formula : C9H12O3

  • Molecular Weight : 168.19

pharmaffiliates